198 related articles for article (PubMed ID: 8035893)
1. [Hepatobiliary disorders in cystic fibrosis].
van de Meeberg PC; Bijleveld CM; Heijerman HG; Houwen RH; Sinaasappel M; van Berge Henegouwen GP
Ned Tijdschr Geneeskd; 1994 Jul; 138(27):1357-60. PubMed ID: 8035893
[No Abstract] [Full Text] [Related]
2. [Pathomorphosis of cystic fibrosis. Current medical and surgical problems in the improved prognosis of cystic fibrosis].
Romano C
Minerva Pediatr; 1981 Jul; 33(14):677-702. PubMed ID: 7027012
[No Abstract] [Full Text] [Related]
3. [Cystic fibrosis: current therapy. Diagnosis and treatment of hepatobiliary diseases].
Spalinger J
Schweiz Med Wochenschr Suppl; 2000; 122():17S-21S. PubMed ID: 12536465
[No Abstract] [Full Text] [Related]
4. Hepatobiliary disease in patients with cystic fibrosis.
Moyer K; Balistreri W
Curr Opin Gastroenterol; 2009 May; 25(3):272-8. PubMed ID: 19381084
[TBL] [Abstract][Full Text] [Related]
5. Hepatobiliary manifestations of cystic fibrosis.
Colombo C; Battezzati PM
Eur J Gastroenterol Hepatol; 1996 Aug; 8(8):748-54. PubMed ID: 8864670
[TBL] [Abstract][Full Text] [Related]
6. [Hepatic complications of mucoviscidosis].
Feigelson J; Pecau Y; Fontaine JL; Navarro J
Med Chir Dig; 1976; 5(7):365-71. PubMed ID: 1018531
[No Abstract] [Full Text] [Related]
7. Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial. The Italian Group for the Study of Ursodeoxycholic Acid in Cystic Fibrosis.
Colombo C; Battezzati PM; Podda M; Bettinardi N; Giunta A
Hepatology; 1996 Jun; 23(6):1484-90. PubMed ID: 8675168
[TBL] [Abstract][Full Text] [Related]
8. [Liver and mucoviscidosis].
Lacaille F
Gastroenterol Clin Biol; 1997; 21(8-9):607-18. PubMed ID: 9587499
[No Abstract] [Full Text] [Related]
9. Hepatobiliary disease in cystic fibrosis.
Colombo C; Battezzati PM; Podda M
Semin Liver Dis; 1994 Aug; 14(3):259-69. PubMed ID: 7939786
[No Abstract] [Full Text] [Related]
10. Endogenous ursodeoxycholic acid and cholic acid in liver disease due to cystic fibrosis.
Smith JL; Lewindon PJ; Hoskins AC; Pereira TN; Setchell KD; O'Connell NC; Shepherd RW; Ramm GA
Hepatology; 2004 Jun; 39(6):1673-82. PubMed ID: 15185309
[TBL] [Abstract][Full Text] [Related]
11. [Question 5. What management in hepatobiliary injury in the course of cystic fibrosis? Specific therapeutic strategy of hepatobiliary injury in the course of cystic fibrosis].
Debray D
Arch Pediatr; 2003 Aug; 10 Suppl 3():490s-494s. PubMed ID: 14671965
[No Abstract] [Full Text] [Related]
12. Natural history of liver disease in cystic fibrosis.
Lindblad A; Glaumann H; Strandvik B
Hepatology; 1999 Nov; 30(5):1151-8. PubMed ID: 10534335
[TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal complications in cystic fibrosis.
Redmond AO
Practitioner; 1980 Mar; 224(1341):295-9. PubMed ID: 7403010
[No Abstract] [Full Text] [Related]
14. Hepatobiliary involvement in adolescents and adults with cystic fibrosis.
Quattrucci S; Angelico M; Stancati M; Bertasi S; Cantusci D; De Sanctis A; Antonelli M
Acta Univ Carol Med (Praha); 1990; 36(1-4):180-2. PubMed ID: 2130690
[TBL] [Abstract][Full Text] [Related]
15. The benign course of liver disease in adults with cystic fibrosis and the effect of ursodeoxycholic acid.
Desmond CP; Wilson J; Bailey M; Clark D; Roberts SK
Liver Int; 2007 Dec; 27(10):1402-8. PubMed ID: 18036103
[TBL] [Abstract][Full Text] [Related]
16. [Liver complications in patients with mucoviscidosis].
Gyurkovits K; Szabó A
Orv Hetil; 1984 Feb; 125(8):437-41. PubMed ID: 6700984
[No Abstract] [Full Text] [Related]
17. Pulmonary prognosis in cystic fibrosis patients with liver disease.
Slieker MG; van der Doef HP; Deckers-Kocken JM; van der Ent CK; Houwen RH
J Pediatr; 2006 Jul; 149(1):144; author reply 144-5. PubMed ID: 16860146
[No Abstract] [Full Text] [Related]
18. Screening for liver disease in cystic fibrosis: analysis of clinical and genetic risk factors for its development.
Fustik S; Trajkovska M; Jakovska T; Spirevska L; Josifovska T; Koceva S
Turk J Pediatr; 2008; 50(6):526-32. PubMed ID: 19227414
[TBL] [Abstract][Full Text] [Related]
19. [Cystic fibrosis associated with liver disease].
Debray D
Arch Pediatr; 2012 May; 19 Suppl 1():S23-6. PubMed ID: 22682485
[TBL] [Abstract][Full Text] [Related]
20. Prediction of liver fibrosis according to serum collagen VI level in children with cystic fibrosis.
Gerling B; Becker M; Staab D; Schuppan D
N Engl J Med; 1997 May; 336(22):1611-2. PubMed ID: 9173266
[No Abstract] [Full Text] [Related]
[Next] [New Search]
